한글목차

광견병 진단 시장 규모는 최근 현저하게 확대하고 있습니다. 2025년 17억 8,000만 달러에서 2026년에는 18억 9,000만 달러로, CAGR 6.6%로 성장이 전망되고 있습니다. 지난 수년간의 성장은 동물의 높은 광견병 발병률, 광견병 예방에 대한 인식 증가, 수의 진단실험실 증가, 광견병 대책에 대한 정부의 구상, 진단 시약 및 키트의 발전 등에 기인하는 것으로 보입니다.

광견병 진단 시장 규모는 향후 수년간 강력한 성장이 전망됩니다. 2030년에는 24억 5,000만 달러에 달하며, CAGR은 6.7%에 달할 전망입니다. 예측 기간 중의 성장에는 AI 기반 진단 툴의 도입, 신속한 현장 검사에 대한 수요 증가, 모바일 기반 질병 감시 확대, 분자 및 혈청학 기술 혁신, 광견병 근절을 위한 민관 협력 강화 등이 주요 요인으로 작용할 것으로 보입니다. 예측 기간의 주요 동향으로는 신속한 현장 광견병 검사, 첨단 분자진단 기술, 광견병 감지에 AI 통합, 모바일 기반 광견병 모니터링 솔루션, 고감도 혈청학 검사 등이 있습니다.

광견병의 확산은 광견병 진단 시장의 성장을 가속할 것으로 예측됩니다. 광견병은 예방 가능한 바이러스성 질환으로, 광견병에 감염된 동물의 물림을 통해 가장 흔하게 감염됩니다. 이 바이러스는 포유류의 중추신경계를 공격하여 결국 뇌 손상과 사망을 유발합니다. 광견병 진단은 다양한 검사와 기술을 통해 인간과 동물에서 광견병 바이러스의 존재를 감지하기 위해 사용됩니다. 또한 동물을 통해 전파되는 전염병의 발생률 증가는 광견병 진단에 대한 수요를 더욱 부추기고 있습니다. 예를 들어 미국 정부 기관인 사우스다코타주 보건국(SD DOH)에 따르면 2024년 4월 기준, 2023년 20마리의 동물이 광견병 양성 판정을 받아 2022년 9마리에 비해 122% 증가했다고 합니다. 광견병에 감염된 동물 중 1마리는 가축(소)이었고, 나머지 19마리는 야생동물(박쥐 18마리, 스컹크 1마리 포함)이었습니다. 따라서 광견병의 확산 확대는 광견병 진단 시장을 촉진할 것으로 예측됩니다.

광견병 진단 시장의 주요 기업은 시장 지위를 유지하기 위해 광견병 항체 검사 키트와 같은 혁신적인 제품을 개발하고 있습니다. 광견병 항체 검사 키트는 혈액내 항체를 검출하여 면역 상태와 추가 광견병 백신 접종 필요성을 평가하는 진단 툴입니다. 예를 들어 2024년 2월 미국 진단 기업 바이오스톤 동물 건강(Biostone Animal Health)는 'AsurDx'를 출시했습니다. 본 키트는 신속하고 민감한 ELISA법을 이용하여 포유류 혈청내 광견병 바이러스 특이 항체를 검출합니다. 백신 접종 동물과 감염 위험이 있는 동물 모두에 대한 광견병 면역 평가에 대한 비용 효율적인 솔루션을 제공합니다. 조작이 쉽고 신뢰할 수 있는 결과를 제공하며, 광견병에 대한 방어 면역 기준인 0.5 국제단위(IU)/ml를 충족하도록 보장합니다.

목차

제1장 개요

제2장 시장의 특징

제3장 시장 공급망 분석

제4장 세계 시장 동향과 전략

제5장 최종 용도 산업의 시장 분석

제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의에 의한 공급망에 대한 영향, Covid가 시장에 미치는 영향을 포함한 거시경제 시나리오

제7장 세계의 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석

제8장 시장의 세계 TAM(Total Addressable Market)

제9장 시장 세분화

제10장 지역별·국가별 분석

제11장 아시아태평양 시장

제12장 중국 시장

제13장 인도 시장

제14장 일본 시장

제15장 호주 시장

제16장 인도네시아 시장

제17장 한국 시장

제18장 대만 시장

제19장 동남아시아 시장

제20장 서유럽 시장

제21장 영국 시장

제22장 독일 시장

제23장 프랑스 시장

제24장 이탈리아 시장

제25장 스페인 시장

제26장 동유럽 시장

제27장 러시아 시장

제28장 북미 시장

제29장 미국 시장

제30장 캐나다 시장

제31장 남미 시장

제32장 브라질 시장

제33장 중동 시장

제34장 아프리카 시장

제35장 시장 규제 상황과 투자환경

제36장 경쟁 구도와 기업 개요

제37장 기타 대기업과 혁신적 기업

제38장 세계의 시장 경쟁 벤치마킹과 대시보드

제39장 주요 합병과 인수

제40장 시장의 잠재력이 높은 국가, 부문, 전략

제41장 부록

영문목차

Rabies diagnostics involve identifying the Rabies disease based on observed conditions and symptoms. This preventable viral illness is commonly transmitted through the bite of a rabid animal. Diagnosis of Rabies typically involves locating the rabies virus within any part of the infected animal's brain. In humans, diagnosis includes testing saliva, serum, spinal fluid, and skin biopsies from hair follicles at the back of the neck.

The methods employed in Rabies diagnostics encompass various tests such as fluorescent antibody tests, immunohistochemical tests, amplification methods, histologic examinations, and serology tests. The fluorescent antibody test (FA) is based on detecting rabies virus proteins (antigen) in the tissues of infected animals. Technologies utilized include ELISA/immunohistochemistry, chromatography techniques, PCR, and others. These diagnostics are commonly employed by hospitals, diagnostic centers, cancer palliative care clinics, and diverse end-users, including pharmacies.

Tariffs have affected the rabies diagnostics market by increasing the cost of imported diagnostic kits, reagents, and molecular testing equipment, creating supply chain bottlenecks for PCR, ELISA, and fluorescent antibody test components. Regions like North America and Europe, which rely on imported precision diagnostic tools, are most impacted, particularly in hospital and diagnostic center segments. On the positive side, tariffs encourage local manufacturing and development of cost-effective diagnostic solutions, boosting regional production capabilities.

The rabies diagnostics market research report is one of a series of new reports from The Business Research Company that provides rabies diagnostics market statistics, including rabies diagnostics industry global market size, regional shares, competitors with a rabies diagnostics market share, detailed rabies diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the rabies diagnostics industry. This rabies diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The rabies diagnostics market size has grown strongly in recent years. It will grow from $1.78 billion in 2025 to $1.89 billion in 2026 at a compound annual growth rate (CAGR) of 6.6%. The growth in the historic period can be attributed to high prevalence of rabies in animals, increasing awareness of rabies prevention, growth of veterinary diagnostic laboratories, government initiatives for rabies control, advancement in diagnostic reagents and kits.

The rabies diagnostics market size is expected to see strong growth in the next few years. It will grow to $2.45 billion in 2030 at a compound annual growth rate (CAGR) of 6.7%. The growth in the forecast period can be attributed to adoption of ai-powered diagnostic tools, rising demand for rapid point-of-care tests, expansion of mobile-based disease surveillance, innovation in molecular and serology techniques, increasing public-private collaborations for rabies eradication. Major trends in the forecast period include rapid point-of-care rabies testing, advanced molecular diagnostic techniques, integration of ai in rabies detection, mobile-based rabies surveillance solutions, high-sensitivity serology testing.

The rising prevalence of rabies is expected to drive growth in the rabies diagnostics market. Rabies is a preventable viral disease most commonly transmitted through the bite of a rabid animal. The virus attacks the central nervous system of mammals, eventually causing brain damage and death. Rabies diagnostics are used to detect the presence of the rabies virus in humans and animals through various tests and techniques. Additionally, the increasing incidence of infectious diseases transmitted by animals has further boosted demand for rabies diagnostics. For example, in April 2024, according to the South Dakota Department of Health (SD DOH), a US-based government agency, South Dakota reported 20 animals testing positive for rabies in 2023, representing a 122% increase compared with 9 cases in 2022. Among the rabid animals, one was a domestic animal (a cow) and the remaining 19 were wild animals, including 18 bats and 1 skunk. Therefore, the growing prevalence of rabies is expected to propel the rabies diagnostics market.

Leading players in the rabies diagnostics market are developing innovative products, such as rabies antibody test kits, to maintain their market position. Rabies antibody test kits are diagnostic tools that detect antibodies in the blood to evaluate immunity or the need for additional rabies vaccination. For example, in February 2024, BioStone Animal Health, a US-based diagnostic company, launched AsurDx. The kit detects antibodies specific to the rabies virus in mammalian serum using a rapid and sensitive ELISA method. It provides a cost-effective solution for assessing rabies immunity in both vaccinated animals and those at risk. The kit is user-friendly, delivers reliable results, and ensures animals meet the standard of 0.5 international units (IU) per ml for protective immunity against rabies.

In November 2025, Zoetis Inc., a US-based provider of animal health medicines, vaccines, and veterinary diagnostic services, acquired Veterinary Pathology Group (VPG) for an undisclosed amount. Through this acquisition, Zoetis expanded its veterinary diagnostics capabilities in the United Kingdom and Ireland, enhancing its laboratory services, including rabies and other infectious disease testing, and improving its ability to deliver faster and more accurate diagnostic insights to veterinary professionals. Veterinary Pathology Group is a UK-based provider of multi-specialty veterinary diagnostic laboratory services, offering a wide range of tests to support clinical decision-making in animal health, including those relevant to rabies surveillance and diagnosis.

Major companies operating in the rabies diagnostics market are Bio-Rad Laboratories Inc., The Merck Group, Aviva Systems Biology Corporation, Creative Diagnostics, Demeditec Diagnostics GmbH, Abbexa Ltd., Norgen Biotek Corp., BioNote Inc., Express Biotech International Inc., MyBioSource Inc., QIAGEN N.V., Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd., Agilent Technologies Inc., Fluidigm Corp., Bio-X Diagnostics S.A., Fujirebio Diagnostics Inc., Gold Standard Diagnostics Corp., Heska Corporation, IDEXX Laboratories Inc., InBios International Inc., KHB Shanghai Kehua Bio-Engineering Co. Ltd., Meridian Bioscience Inc., MP Biomedicals LLC, Neogen Corporation, Randox Laboratories Ltd., SDIX LLC, Sigma-Aldrich Corporation

North America was the largest region in the rabies diagnostics market in 2025. The regions covered in the rabies diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the rabies diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The rabies diagnostics market includes revenues earned by entities by providing diagnostic services such as reverse transcription followed by polymerase chain reaction (RT-PCR), virus isolation, and direct fluorescent antibody (DFA) tests. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Rabies Diagnostics Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses rabies diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for rabies diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The rabies diagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Diagnostic Method: Fluorescent Antibody Test; Immunohistochemical Test; Amplification Methods; Histologic Examination; Serology Tests
• 2) By Technology: ELISA Or Immunohistochemistry; Chromatography Techniques; PCR; Other Technologies
• 3) By End-User: Hospital; Diagnostic Centers; Cancer Palliative Care Clinics; Other End-Users
• Subsegments:
• 1) By Fluorescent Antibody Test: Direct Fluorescent Antibody Test (DFA)
• 2) By Immunohistochemical: Enzyme-Linked Immunosorbent Assay (ELISA); Western Blotting
• 3) By Amplification Methods: Polymerase Chain Reaction (PCR); Reverse Transcription PCR (RT-PCR)
• 4) By Histologic Examination: Microscopic Examination; Tissue Staining Techniques
• 5) By Serology Tests: Virus Neutralization Test (VNT); Enzyme-Linked Immunosorbent Assay (ELISA)
• Companies Mentioned: Bio-Rad Laboratories Inc.; The Merck Group; Aviva Systems Biology Corporation; Creative Diagnostics; Demeditec Diagnostics GmbH; Abbexa Ltd.; Norgen Biotek Corp.; BioNote Inc.; Express Biotech International Inc.; MyBioSource Inc.; QIAGEN N.V.; Thermo Fisher Scientific Inc.; F. Hoffmann-La Roche Ltd.; Agilent Technologies Inc.; Fluidigm Corp.; Bio-X Diagnostics S.A.; Fujirebio Diagnostics Inc.; Gold Standard Diagnostics Corp.; Heska Corporation; IDEXX Laboratories Inc.; InBios International Inc.; KHB Shanghai Kehua Bio-Engineering Co. Ltd.; Meridian Bioscience Inc.; MP Biomedicals LLC; Neogen Corporation; Randox Laboratories Ltd.; SDIX LLC; Sigma-Aldrich Corporation
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Rabies Diagnostics Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Rabies Diagnostics Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Rabies Diagnostics Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Rabies Diagnostics Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Biotechnology, Genomics & Precision Medicine
  • 4.1.2 Artificial Intelligence & Autonomous Intelligence
  • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.4 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
  • 4.1.5 Industry 4.0 & Intelligent Manufacturing
• 4.2. Major Trends
  • 4.2.1 Rapid Point-Of-Care Rabies Testing
  • 4.2.2 Advanced Molecular Diagnostic Techniques
  • 4.2.3 Integration Of Ai In Rabies Detection
  • 4.2.4 Mobile-Based Rabies Surveillance Solutions
  • 4.2.5 High-Sensitivity Serology Testing

5. Rabies Diagnostics Market Analysis Of End Use Industries

• 5.1 Hospital
• 5.2 Diagnostic Centers
• 5.3 Cancer Palliative Care Clinics
• 5.4 Research Laboratories
• 5.5 Veterinary Clinics

6. Rabies Diagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Rabies Diagnostics Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Rabies Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Rabies Diagnostics Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Rabies Diagnostics Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Rabies Diagnostics Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Rabies Diagnostics Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Rabies Diagnostics Market Segmentation

• 9.1. Global Rabies Diagnostics Market, Segmentation By Diagnostic Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Fluorescent Antibody Test, Immunohistochemical Test, Amplification Methods, Histologic Examination, Serology Tests
• 9.2. Global Rabies Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• ELISA Or Immunohistochemistry, Chromatography Techniques, PCR, Other Technologies
• 9.3. Global Rabies Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Hospital, Diagnostic Centers, Cancer Palliative Care Clinics, Other End-Users
• 9.4. Global Rabies Diagnostics Market, Sub-Segmentation Of Fluorescent Antibody Test, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Direct Fluorescent Antibody Test (DFA)
• 9.5. Global Rabies Diagnostics Market, Sub-Segmentation Of Immunohistochemical, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Enzyme-Linked Immunosorbent Assay (ELISA), Western Blotting
• 9.6. Global Rabies Diagnostics Market, Sub-Segmentation Of Amplification Methods, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Polymerase Chain Reaction (PCR), Reverse Transcription PCR (RT-PCR)
• 9.7. Global Rabies Diagnostics Market, Sub-Segmentation Of Histologic Examination, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Microscopic Examination, Tissue Staining Techniques
• 9.8. Global Rabies Diagnostics Market, Sub-Segmentation Of Serology Tests, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Virus Neutralization Test (VNT), Enzyme-Linked Immunosorbent Assay (ELISA)

10. Rabies Diagnostics Market Regional And Country Analysis

• 10.1. Global Rabies Diagnostics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Rabies Diagnostics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Rabies Diagnostics Market

• 11.1. Asia-Pacific Rabies Diagnostics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Rabies Diagnostics Market, Segmentation By Diagnostic Method, Segmentation By Technology, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Rabies Diagnostics Market

• 12.1. China Rabies Diagnostics Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Rabies Diagnostics Market, Segmentation By Diagnostic Method, Segmentation By Technology, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Rabies Diagnostics Market

• 13.1. India Rabies Diagnostics Market, Segmentation By Diagnostic Method, Segmentation By Technology, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Rabies Diagnostics Market

• 14.1. Japan Rabies Diagnostics Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Rabies Diagnostics Market, Segmentation By Diagnostic Method, Segmentation By Technology, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Rabies Diagnostics Market

• 15.1. Australia Rabies Diagnostics Market, Segmentation By Diagnostic Method, Segmentation By Technology, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Rabies Diagnostics Market

• 16.1. Indonesia Rabies Diagnostics Market, Segmentation By Diagnostic Method, Segmentation By Technology, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Rabies Diagnostics Market

• 17.1. South Korea Rabies Diagnostics Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Rabies Diagnostics Market, Segmentation By Diagnostic Method, Segmentation By Technology, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Rabies Diagnostics Market

• 18.1. Taiwan Rabies Diagnostics Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Rabies Diagnostics Market, Segmentation By Diagnostic Method, Segmentation By Technology, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Rabies Diagnostics Market

• 19.1. South East Asia Rabies Diagnostics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Rabies Diagnostics Market, Segmentation By Diagnostic Method, Segmentation By Technology, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Rabies Diagnostics Market

• 20.1. Western Europe Rabies Diagnostics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Rabies Diagnostics Market, Segmentation By Diagnostic Method, Segmentation By Technology, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Rabies Diagnostics Market

• 21.1. UK Rabies Diagnostics Market, Segmentation By Diagnostic Method, Segmentation By Technology, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Rabies Diagnostics Market

• 22.1. Germany Rabies Diagnostics Market, Segmentation By Diagnostic Method, Segmentation By Technology, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Rabies Diagnostics Market

• 23.1. France Rabies Diagnostics Market, Segmentation By Diagnostic Method, Segmentation By Technology, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Rabies Diagnostics Market

• 24.1. Italy Rabies Diagnostics Market, Segmentation By Diagnostic Method, Segmentation By Technology, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Rabies Diagnostics Market

• 25.1. Spain Rabies Diagnostics Market, Segmentation By Diagnostic Method, Segmentation By Technology, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Rabies Diagnostics Market

• 26.1. Eastern Europe Rabies Diagnostics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Rabies Diagnostics Market, Segmentation By Diagnostic Method, Segmentation By Technology, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Rabies Diagnostics Market

• 27.1. Russia Rabies Diagnostics Market, Segmentation By Diagnostic Method, Segmentation By Technology, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Rabies Diagnostics Market

• 28.1. North America Rabies Diagnostics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Rabies Diagnostics Market, Segmentation By Diagnostic Method, Segmentation By Technology, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Rabies Diagnostics Market

• 29.1. USA Rabies Diagnostics Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Rabies Diagnostics Market, Segmentation By Diagnostic Method, Segmentation By Technology, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Rabies Diagnostics Market

• 30.1. Canada Rabies Diagnostics Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Rabies Diagnostics Market, Segmentation By Diagnostic Method, Segmentation By Technology, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Rabies Diagnostics Market

• 31.1. South America Rabies Diagnostics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Rabies Diagnostics Market, Segmentation By Diagnostic Method, Segmentation By Technology, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Rabies Diagnostics Market

• 32.1. Brazil Rabies Diagnostics Market, Segmentation By Diagnostic Method, Segmentation By Technology, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Rabies Diagnostics Market

• 33.1. Middle East Rabies Diagnostics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Rabies Diagnostics Market, Segmentation By Diagnostic Method, Segmentation By Technology, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Rabies Diagnostics Market

• 34.1. Africa Rabies Diagnostics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Rabies Diagnostics Market, Segmentation By Diagnostic Method, Segmentation By Technology, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Rabies Diagnostics Market Regulatory and Investment Landscape

36. Rabies Diagnostics Market Competitive Landscape And Company Profiles

• 36.1. Rabies Diagnostics Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Rabies Diagnostics Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Rabies Diagnostics Market Company Profiles
  • 36.3.1. Bio-Rad Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. The Merck Group Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. Aviva Systems Biology Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. Creative Diagnostics Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. Demeditec Diagnostics GmbH Overview, Products and Services, Strategy and Financial Analysis

37. Rabies Diagnostics Market Other Major And Innovative Companies

• Abbexa Ltd., Norgen Biotek Corp., BioNote Inc., Express Biotech International Inc., MyBioSource Inc., QIAGEN N.V., Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd., Agilent Technologies Inc., Fluidigm Corp., Bio-X Diagnostics S.A., Fujirebio Diagnostics Inc., Gold Standard Diagnostics Corp., Heska Corporation, IDEXX Laboratories Inc.

38. Global Rabies Diagnostics Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Rabies Diagnostics Market

40. Rabies Diagnostics Market High Potential Countries, Segments and Strategies

• 40.1 Rabies Diagnostics Market In 2030 - Countries Offering Most New Opportunities
• 40.2 Rabies Diagnostics Market In 2030 - Segments Offering Most New Opportunities
• 40.3 Rabies Diagnostics Market In 2030 - Growth Strategies
  • 40.3.1 Market Trend Based Strategies
  • 40.3.2 Competitor Strategies

41. Appendix

• 41.1. Abbreviations
• 41.2. Currencies
• 41.3. Historic And Forecast Inflation Rates
• 41.4. Research Inquiries
• 41.5. The Business Research Company
• 41.6. Copyright And Disclaimer